Gene therapy: An Extensive Overview
Recent advances in the field of genetic engineering are expanding the capability of gene therapy to treat diseases, notably those previously unreachable. As a proof, the last two years saw the number of marketing authorization for gene therapy products significantly rise. Last month, Novartis has obtained Canadian approvement for its CAR-T Therapy, Kymriah. For its […]
CAR-Based Immunotherapy
We would like to share some exciting results on CAR-Based Immunotherapy. It comes from our partner Dr Oana Gavriliuc from OncoGen “Victor Babes” University of Medicine and Pharmacy, Timisoara (Romania). We are proud to introduce the poster presented by Dr Gavriliuc at the ICLE 2019 (London). The poster titled CAR-Based Immunotherapy of EGFR positive solid tumors using […]
ANCHOR Technology / Partnership
We are proud to annonce you that GEG Tech has validated the combination of the ANCHOR technology developed by NeoVirTech with our Lenti-ONE vectors. This breakthrough technology allowed us to generate the first auto-fluorescent lentiviral vectors for live imaging and screening applications. For more details about the new possibilities offered by the ANCHOR Lenti-ONE, please take a look here. And […]
Preclinical and Personalized Breast Cancer Research
As scientists involved in life science research, we would like to let you know about the research project on breast cancer, led by the Brisken Lab in EPFL, Switzerland. The scientific team of GEG Tech is proud to be a part of it, designing advanced vectorization systems required by this promising research. Please find a […]
